
|Articles|February 1, 1996
The American Journal of Managed Care
- February 1996
- Volume 2
- Issue 2
Pharmacoeconomic Impact of Injectable Sumatriptan on Migraine-Associated Healthcare Costs
Advertisement
Articles in this issue
almost 30 years ago
Adapting Pharmacy Services to the Needs of Managed Carealmost 30 years ago
Advanced Practice Nurses and Success of Organized Delivery Systemsalmost 30 years ago
Ethical Issues in Managed Carealmost 30 years ago
The Economics of Compliance in Managed Healthcare SettingsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss
2
Patients With CKD Are Less Likely to Receive Adjuvant Chemotherapy
3
Obstructive Sleep Apnea Identified as Potential Risk Factor for Parkinson Disease
4
ICYMI: Highlights From ESMO 2025
5







































